Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1989 Sep;135(3):489–497.

Endotoxin-induced shock in the rat. A role for C5a.

G Smedegård 1, L X Cui 1, T E Hugli 1
PMCID: PMC1879876  PMID: 2789475

Abstract

Administration of endotoxin from gram-negative bacteria to rats results in systemic hypotension, an increased hematocrit, and decreased numbers of circulating leukocytes (polymorphonuclear), monocytes, and platelets. These potentially lethal physiologic changes may be partially attributed to complement activation and generation of anaphylatoxins by the endotoxin (LPS). We demonstrated an elevation in the plasma levels of both C3a and C5a in LPS-treated rats. Injection of 5 micrograms C5ades Arg (rat) into rats produced effects similar to those induced by LPS, including decreased mean arterial pressure (systemic hypotension) and decreased numbers of circulating polymorphonuclear leukocytes, monocytes, and platelets. Unlike the response to LPS, C5a did not increase the hematocrit, indicating little effect on vascular permeability at the doses used. When LPS-treated animals were pretreated with F(ab')2 fragments of rabbit anti-rat C5a, no changes were measured in the circulating cell counts compared with LPS alone; however a significant improvement in the mean arterial pressure and a decrease in hematocrit was observed. We conclude that LPS-induced (septic) shock in the rat may result, in part, from the effects of complement activation and particularly from the generation of C5a. The influence of C5a on the LPS effect in the rat appears to enhance both the hypotensive (mean arterial pressure) and vascular permeability (hematocrit) responses. These results appear to support and confirm earlier observations that anti-human C5a increased survival in a septic-shock monkey model by eliminating circulating C5a and presumably thereby reducing the effects of endotoxin on blood pressure. Our results demonstrate that C5a plays a significant role in the hemodynamic changes associated with endotoxin-induced shock. Neutralization of C5a with specific antibodies may reduce the hypotensive response to endotoxin sufficiently to prevent lethal septic shock both in animals and in man.

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betz M., Seitz M., Hänsch G. M. Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9. Int Arch Allergy Appl Immunol. 1987;82(3-4):313–316. doi: 10.1159/000234215. [DOI] [PubMed] [Google Scholar]
  2. Björk J., Hugli T. E., Smedegård G. Microvascular effects of anaphylatoxins C3a and C5a. J Immunol. 1985 Feb;134(2):1115–1119. [PubMed] [Google Scholar]
  3. Bodammer G., Vogt W. Actions of anaphylatoxin on circulation and respiration of the guinea pig. Int Arch Allergy Appl Immunol. 1967;32(5):417–428. doi: 10.1159/000229953. [DOI] [PubMed] [Google Scholar]
  4. Brigham K. L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  7. Cook J. A., Wise W. C., Halushka P. V. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat. J Pharmacol Exp Ther. 1985 Nov;235(2):470–474. [PubMed] [Google Scholar]
  8. Doebber T. W., Wu M. S., Robbins J. C., Choy B. M., Chang M. N., Shen T. Y. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun. 1985 Mar 29;127(3):799–808. doi: 10.1016/s0006-291x(85)80014-0. [DOI] [PubMed] [Google Scholar]
  9. Duchateau J., Haas M., Schreyen H., Radoux L., Sprangers I., Noel F. X., Braun M., Lamy M. Complement activation in patients at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis. 1984 Dec;130(6):1058–1064. doi: 10.1164/arrd.1984.130.6.1058. [DOI] [PubMed] [Google Scholar]
  10. Fearon D. T., Ruddy S., Schur P. H., McCabe W. R. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med. 1975 May 1;292(18):937–940. doi: 10.1056/NEJM197505012921802. [DOI] [PubMed] [Google Scholar]
  11. Fletcher J. R., Ramwell P. W. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol. 1977 Oct;61(2):175–181. doi: 10.1111/j.1476-5381.1977.tb08402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Flick M. R., Horn J. K., Hoeffel J. M., Goldstein I. M. Reduction of total hemolytic complement activity with Naja haje cobra venom factor does not prevent endotoxin-induced lung injury in sheep. Am Rev Respir Dis. 1986 Jan;133(1):62–67. doi: 10.1164/arrd.1986.133.1.62. [DOI] [PubMed] [Google Scholar]
  13. From A. H., Gewurz H., Gruninger R. P., Pickering R. J., Spink W. W. Complement in endotoxin shock: effect of complement depletion on the early hypotensive phase. Infect Immun. 1970 Jul;2(1):38–41. doi: 10.1128/iai.2.1.38-41.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garner R., Chater B. V., Brown D. L. The role of complement in endotoxin shock and disseminated intravascular coagulation: experimental observations in the dog. Br J Haematol. 1974 Nov;28(3):393–401. doi: 10.1111/j.1365-2141.1974.tb00820.x. [DOI] [PubMed] [Google Scholar]
  15. Gerard C., Hugli T. E. Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. J Biol Chem. 1979 Jul 25;254(14):6346–6351. [PubMed] [Google Scholar]
  16. Hammerschmidt D. E., Bowers T. K., Lammi-Keefe C. J., Jacob H. S., Craddock P. R. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood. 1980 Jun;55(6):898–902. [PubMed] [Google Scholar]
  17. Hammerschmidt D. E., Weaver L. J., Hudson L. D., Craddock P. R., Jacob H. S. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet. 1980 May 3;1(8175):947–949. doi: 10.1016/s0140-6736(80)91403-8. [DOI] [PubMed] [Google Scholar]
  18. Hugli T. E., Gerard C., Kawahara M., Scheetz M. E., 2nd, Barton R., Briggs S., Koppel G., Russell S. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem. 1981 Dec 4;41:59–66. doi: 10.1007/BF00225297. [DOI] [PubMed] [Google Scholar]
  19. Hugli T. E., Marceau F., Lundberg C. Effects of complement fragments on pulmonary and vascular smooth muscle. Am Rev Respir Dis. 1987 Jun;135(6 Pt 2):S9–13. doi: 10.1164/arrd.1987.135.6P2.S9. [DOI] [PubMed] [Google Scholar]
  20. Hyers T. M., Fowler A. A. Adult respiratory distress syndrome: causes, morbidity, and mortality. Fed Proc. 1986 Jan;45(1):25–29. [PubMed] [Google Scholar]
  21. Imagawa D. K., Osifchin N. E., Ramm L. E., Koga P. G., Hammer C. H., Shin H. S., Mayer M. M. Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation. J Immunol. 1986 Jun 15;136(12):4637–4643. [PubMed] [Google Scholar]
  22. Jacobs E. R., Soulsby M. E., Bone R. C., Wilson F. J., Jr, Hiller F. C. Ibuprofen in canine endotoxin shock. J Clin Invest. 1982 Sep;70(3):536–541. doi: 10.1172/JCI110645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lundberg C., Marceau F., Hugli T. E. C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes. Am J Pathol. 1987 Sep;128(3):471–483. [PMC free article] [PubMed] [Google Scholar]
  24. Meyrick B. O. Endotoxin-mediated pulmonary endothelial cell injury. Fed Proc. 1986 Jan;45(1):19–24. [PubMed] [Google Scholar]
  25. Natvig J. B., Turner M. W. Localization of Gm markers to different molecular regions of the Fc fragment. Clin Exp Immunol. 1971 May;8(5):685–700. [PMC free article] [PubMed] [Google Scholar]
  26. Olson L. M., Moss G. S., Baukus O., Das Gupta T. K. The role of C5 in septic lung injury. Ann Surg. 1985 Dec;202(6):771–776. doi: 10.1097/00000658-198512000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
  28. Pavek K., Piper P. J., Smedegård G. Anaphylatoxin-induced shock and two patterns of anaphylactic shock: hemodynamics and mediators. Acta Physiol Scand. 1979 Apr;105(4):393–403. doi: 10.1111/j.1748-1716.1979.tb00103.x. [DOI] [PubMed] [Google Scholar]
  29. Phillips J. K., Snyderman R., Mergenhagen S. E. Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes. J Immunol. 1972 Aug;109(2):334–341. [PubMed] [Google Scholar]
  30. Pingleton W. W., Coalson J. J., Guenter C. A. Significance of leukocytes in endotoxic shock. Exp Mol Pathol. 1975 Apr;22(2):183–194. doi: 10.1016/0014-4800(75)90062-3. [DOI] [PubMed] [Google Scholar]
  31. Rampart M., Bult H., Herman A. G. Contribution of complement activation to the rise in blood levels of 6-oxo-prostaglandin F1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol. 1982 Apr 8;79(1-2):91–99. doi: 10.1016/0014-2999(82)90578-7. [DOI] [PubMed] [Google Scholar]
  32. Rampart M., Zonnekeyn L., Bult H., Herman A. G. Prostacyclin biosynthesis and hypotension in relation to complement activation in rabbit endotoxic shock. Biomed Biochim Acta. 1984;43(8-9):S191–S194. [PubMed] [Google Scholar]
  33. Rousseaux J., Rousseaux-Prévost R., Bazin H. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses. J Immunol Methods. 1983 Nov 11;64(1-2):141–146. doi: 10.1016/0022-1759(83)90392-7. [DOI] [PubMed] [Google Scholar]
  34. Stevens J. H., O'Hanley P., Shapiro J. M., Mihm F. G., Satoh P. S., Collins J. A., Raffin T. A. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest. 1986 Jun;77(6):1812–1816. doi: 10.1172/JCI112506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ulevitch R. J., Cochrane C. G. Complement-dependent hemodynamic and hematologic changes in the rabbit. Inflammation. 1977 Sep;2(3):199–216. doi: 10.1007/BF00917596. [DOI] [PubMed] [Google Scholar]
  36. Ulevitch R. J., Cochrane C. G., Henson P. M., Morrison D. C., Doe W. F. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med. 1975 Dec 1;142(6):1570–1590. doi: 10.1084/jem.142.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Winn R., Harlan J., Nadir B., Harker L., Hildebrandt J. Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. J Clin Invest. 1983 Sep;72(3):911–918. doi: 10.1172/JCI111062. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES